Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor*

Abstract

The amyloid protein, Aβ, which accumulates in the brains of Alzheimer patients, is derived by proteolysis of the amyloid protein precursor (APP). APP can undergo endoproteolytic processing at three sites, one at the amino terminus of the Aβ domain (β-cleavage), one within the Aβ domain (α-cleavage), and one at the carboxyl terminus of the Aβ domain (γ-cleavage). The enzymes responsible for these activities have not been unambiguously identified. By the use of gene disruption (knockout), we now demonstrate that TACE (tumor necrosis factor α converting enzyme), a member of the ADAM family (a disintegrinand metalloprotease-family) of proteases, plays a central role in regulated α-cleavage of APP. Our data suggest that TACE may be the α-secretase responsible for the majority of regulated α-cleavage in cultured cells. Furthermore, we show that inhibiting this enzyme affects both APP secretion and Aβ formation in cultured cells.

Footnotes

  • * This work was supported by a James A. Shannon Director’s Award (to J. D. B.), an ADRC Pilot Project Award (to J. D. B.), and NIA, National Institutes of Health Grant AG14996 (to J. D. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • § To whom correspondence should be addressed: Dept. of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029. Tel.: 212-241-2693; Fax: 212-828-4221; E-mail:buxbaj01{at}doc.mssm.edu.

  • Abbreviations:
    APP

    amyloid protein precursor

    APPs

    secreted APP

    TNF-α

    tumor necrosis factor α

    TACE

    TNF-α converting enzyme

    IC3

    Immunex compound 3

    HPLC

    high performance liquid chromatography

    PMA

    phorbol 12-myristate 13-acetate

    PDBu

    phorbol 12,13-dibutyrate

    Tricine

    N-[2-hydroxy-1,1-bis(hydroxymethyl) ethyl]glycine.

    • Received July 28, 1998.
    • Revision received August 28, 1998.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement